Oculentis区域折射多焦点人工晶状体植入术后早期疗效观察

目的：探讨Oculentis区域折射多焦点人工晶状体植入术后早期临床疗效。

方法：将2016-10/2017-01行超声乳化吸出术联合Oculentis区域折射多焦点人工晶状体植入术的白内障患者20例作为试验组，将同一时段行超声乳化吸出联合人类光学Aspira-aA单焦点非球面人工晶状体植入术的白内障患者20例作为对照组。检查患者术后3mo裸眼远视力、近视力、屈光状态、UBM检查、阅读戴镜率、不良体验率(光晕、眩光、雾视等现象发生率)的情况。

结果：术后3mo，试验组裸眼远视力(0.10±0.03)与对照组比较差异无统计学意义(t=1.74，P>0.05)。试验组裸眼近视力(0.11±0.04)与对照组比较差异有统计学意义(t=15.53，P<0.05)。术后3mo，试验组人工晶状体居中性均良好，阅读戴镜率为5%，不良体验率(光晕、眩光、雾视现象发生率)仅为5%，而对照组阅读戴镜率为100%。

结论：Oculentis区域折射多焦点人工晶状体植入术可提供良好的裸眼远视力和近视力，能极大地提高白内障术后脱镜率，解决白内障术后老视问题，且患者舒适度极佳，光晕、眩光、雾视现象少有发生，手术安全可靠。

Visual outcome with the Oculentis Mplus intraocular lens

AIM: To evaluate the visual outcome of Oculentis Mplus intraocular lens(IOL).

METHODS: Totally 20 eyes in 20 patients received phacoemulsification and Oculentis Mplus intraocular lens implantation were as test group, and 20 eyes(Aspira-aA IOL)were as control group. The following postoperative examinations were performed after operation for 3mo: uncorrected visual acuity of distance and near, refractive results, UBM examination, the rate of wearing spectacles and the complications.

RESULTS: At 3mo after surgery, distance visual acuity of test group with Oculentis Mplus IOL were 0.10±0.03,the difference with control group was not significant(t=1.74, P>0.05). Eyes in test group had an uncorrected near acuity 0.11±0.04, the difference with control group was significant(t=15.53, P<0.05). The rate of wearing spectacles was 5% in test group and 100% in control group. The rate of uncomfortableness was 5% in test group.

CONCLUSION: The implantation of Oculentis Mplus IOL not only has a good distance uncorrected visual acuity, but also with better near visual acuity. The surgery is safe, reliable and no special complication induced.